መነሻ › ስቴቶቲክ የጉበት በሽታ › New York › New York City
በNew York City፣ NY ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለስቴቶቲክ የጉበት በሽታ የሚደረጉ 16 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
ተሳታዮችን በመፈለግ ላይደረጃ 3
- 89bio Clinical Study Site, New York
- 89bio Clinical Study Site, New York
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- 89bio Clinical Study Site, New York
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, New York
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
ተሳታዮችን በመፈለግ ላይደረጃ 2
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Columbia University Irving Medical Center, New York
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- NYU Langone Health, New York
- IMA Clinical Research Manhattan, New York
- New York Gastroenterology Associates, New York
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
- Akero Clinical Study Site, New York
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, New York
Human Models of Selective Insulin Resistance: Alpelisib, Part I
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
- Columbia University Irving Medical Center, New York
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- GSK Investigational Site, New York
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
ተሳታዮችን በመፈለግ ላይደረጃ 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
ተሳታዮችን በመፈለግ ላይደረጃ 2
- GSK Investigational Site, New York
Effect of Insulin Lowering on Lipogenesis
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Columbia University Irving Medical Center, New York
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
ተሳታዮችን በመፈለግ ላይ
- Icahn School of Medicine at Mount Sinai, New York
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Weill Cornell Medicine, New York
High Fructose Diet, the Gut Microbiome, and Metabolic Health
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Mount Sinai Morningside, New York
በሌሎች ከተሞች ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ጥናቶች
- San Antonio, TX17 ጥናቶች
- Miami, FL16 ጥናቶች
- San Diego, CA14 ጥናቶች
- Austin, TX13 ጥናቶች
- Houston, TX13 ጥናቶች
- Richmond, VA12 ጥናቶች
- Tucson, AZ10 ጥናቶች
- Chandler, AZ10 ጥናቶች
- Hialeah, FL9 ጥናቶች
- Dallas, TX9 ጥናቶች
- Orlando, FL9 ጥናቶች
- St. Louis, MO9 ጥናቶች
በNew York City ውስጥ ያሉ ሌሎች ጥናቶች
- የጡንቻ ካንሰር136 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር121 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)109 ጥናቶች
- የፕሮስቴት ካንሰር103 ጥናቶች
- Metastatic Cancer93 ጥናቶች
- የኮሎሬክታል ካንሰር78 ጥናቶች
- የእንቁላል ካንሰር69 ጥናቶች
- የሳንባ ካንሰር60 ጥናቶች
- Multiple Myeloma60 ጥናቶች
- የፓንክሪያስ ካንሰር60 ጥናቶች
- የኤንዶሜትሪየም ካንሰር52 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ51 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።